Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Two prognostic groups of inflammatory breast cancer have distinct genotypes.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2003

Lerebours Florence, Bertheau Philippe, Bieche Ivan, Plassa Louis-François, Champeme Marie-Helene, Hacene Kamel, Toulas Christine, Espie Marc, Marty Michel, Lidereau Rosette

Abstract excerpt

PURPOSE: The prognosis of inflammatory breast cancer (IBC) remains poor despite the use of multimodality treatments, with a 10-year survival rate of not >30%. Clinicopathological and biological predictors of outcome are inadequate in this setting. Analysis of loss of heterozygosity (LOH) can prov...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Mapping

Share to Loss of Heterozygosity

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Survival Analysis

Share to Time Factors

Source

Identifiers

PMID: 14519644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14519644-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Two prognostic groups of inflammatory breast cancer have distinct genotypes.PMID 14519644Read ↗

Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational ProfilingSemantic proximity Read ↗

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.Semantic proximity Read ↗

Clinicogenomic characterization of inflammatory breast cancerSemantic proximity Read ↗

Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy.Semantic proximity Read ↗

BRCA mutations in women with inflammatory breast cancer.Semantic proximity Read ↗

Gene expression profiling of inflammatory breast cancerSemantic proximity Read ↗

Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.Semantic proximity Read ↗

Mutational landscape of inflammatory breast cancer.Semantic proximity Read ↗

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic PerspectivesSemantic proximity Read ↗

Molecular determinants of the inflammatory breast cancer phenotype.Semantic proximity Read ↗

Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.Semantic proximity Read ↗

Molecular Profiling of Inflammatory Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.